Pro-apoptotic therapy with the oligonucleotide Genasense™ (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumour activity of rituximab

Jeyanthi Ramanarayanan, Francisco J. Hernandez-Ilizaliturri, Asher Chanan-Khan, Myron S. Czuczman

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Pro-apoptotic therapy with the oligonucleotide Genasense™ (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumour activity of rituximab'. Together they form a unique fingerprint.

Medicine & Life Sciences